Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Models of Reactive Oxygen Species in Cancer

The role of cellular reactive oxygen species in cancer chemotherapy

Metabolic Regulation of Redox Balance in Cancer

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

The double-edged roles of ROS in cancer prevention and therapy

Reactive Oxygen Species: a Double-Edged Sword in Oncogenesis.

Targeting ROS in cancer: rationale and strategies

Roles of Reactive Oxygen Species in Inflammation and Cancer

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Reactive Oxygen Species Mechanisms that Regulate Protein–Protein Interactions in Cancer

Redox regulation of microRNAs in cancer.

Induction of Reactive Oxygen Species: an Emerging Approach for Cancer Therapy

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Modulation of reactive oxygen species in cancers: recent advances

Oxidative Stress in Cancer Cell Metabolism

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Controlling Cancer Cells Using Reactive Oxygen Species

Reactive Oxygen Species and Colorectal Cancer

Regulation of reactive oxygen species in stem cells and cancer stem cells